Key Laboratory of New Drugs Design and Discovery of Liaoning Province School of Pharmaceutical Engineering Shenyang Pharmaceutical University Shenyang P.R.China;
Signal Transduction Program Burnham Institute for Medical Research 10901 N Torrey Pines Rd La Jolla CA 92037 USA;
Key Laboratory of Cell Biology of Ministry of Public Health of China Department of Cell Biology China Medical University Shenyang P.R.China;
Key Laboratory of New Drugs Design and Disc;
p21-activated kinase 4; pharmacophore model; molecular docking; kinase inhibitor; drug discovery;
机译:PAK4抑制剂的药理学鉴定
机译:通过多种电子药物,配体的药仔,分子对接和密度泛函理论方法鉴定选择性MMP-9抑制剂
机译:基于选择药效团产生子集的新方法的药效团建模,鉴定Pim-1激酶的新型抑制剂
机译:PAK4抑制剂的药物鉴定
机译:从新型药理学上的吡喃并[2,3-d]嘧啶-7-一合成有效的Abelson激酶抑制剂
机译:PAK4相互作用组的鉴定揭示了N-WASP的PAK4磷酸化和Arp2 / 3依赖的肌动蛋白聚合反应的促进
机译:PAK4蛋白酶的鉴定揭示了N-WASP的PAK4磷酸化和ARP2 / 3依赖性肌动蛋白聚合的促进